Ftse Mib
34.145,86
-0,28%
DAX
18.488,07
0,27%
S&P 500
5.182,56
-0,10%
NASDAQ
16.296,35
-0,22%
Bitcoin
62.299,00
-0,06%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ HOOKIPA Pharma Inc (HOOK) HOOKIPA Pharma Inc (HOOK) Notizie

HOOKIPA Pharma Inc

HOOK
0,791
-0,036 (-4,35%)
Ultimo aggiornamento: 17:33:33
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202413:01GLOBEHOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for..
24/4/202413:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
16/4/202422:30GLOBEHOOKIPA Pharma Announces Grant of Inducement Award Under..
10/4/202413:01GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 and Planned..
22/3/202412:01GLOBEHOOKIPA Pharma Reports Fourth Quarter and Full Year 2023..
06/3/202413:01GLOBEHOOKIPA Pharma to Participate in Leerink Partners Global..
31/1/202422:30EDGAR2Form 8-K - Current report
29/1/202414:12EDGAR2Form 8-K - Current report
29/1/202414:01GLOBEHOOKIPA Pharma Provides Update on Business Priorities and..
16/1/202413:01GLOBEHOOKIPA Pharma Appoints Mark Winderlich as Chief Development..
05/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/12/202313:33EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202313:06EDGAR2Form 8-K - Current report
21/12/202313:01GLOBEHOOKIPA Pharma Announces $21.25 Million Equity Investment..
01/12/202322:46EDGAR2Form 8-K - Current report
20/11/202313:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
09/11/202313:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:05EDGAR2Form 8-K - Current report
09/11/202313:01GLOBEHOOKIPA Pharma Reports Third Quarter 2023 Financial..
03/11/202317:01GLOBEHOOKIPA Pharma Presents Positive Biomarker and Translational..
02/11/202321:01GLOBEHOOKIPA Pharma to Report Third Quarter 2023 Financial..
22/10/202312:01GLOBEHOOKIPA Pharma Presents Additional Preliminary Phase 2 Data..
20/10/202322:05EDGAR2Form 8-K - Current report
18/10/202313:01GLOBEHOOKIPA Pharma announces publication of preclinical data of..
13/9/202314:47EDGAR2Form 8-K - Current report
13/9/202314:45GLOBEHOOKIPA Announces Executive Leadership Change
12/9/202314:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/9/202313:01GLOBEHOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
06/9/202313:01GLOBEHOOKIPA Pharma to participate in upcoming investor..
22/8/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:13EDGAR2Form SC TO-I - Tender offer statement by Issuer
10/8/202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:05EDGAR2Form 8-K - Current report
10/8/202313:01GLOBEHOOKIPA Pharma Reports Second Quarter 2023 Financial Results..
04/8/202322:10EDGAR2Form 8-K - Current report
03/8/202313:01GLOBEHOOKIPA Pharma to Report Second Quarter 2023 Financial..
03/7/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202311:00GLOBEHOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
01/6/202303:30GLOBEHOOKIPA Pharma Announces Pricing of $50.0 Million Public..
31/5/202322:45GLOBEHOOKIPA Pharma Announces Positive Preliminary Phase 2 Data..
11/5/202313:01GLOBEHOOKIPA Pharma Reports First Quarter 2023 Financial..
09/5/202313:01GLOBEHOOKIPA Announces First Person Dosed in Phase 1a/b Clinical..
Apertura: 0,845 Min: 0,791 Max: 0,8499
Chiusura: 0,827

La tua Cronologia

NASDAQ
HOOK
HOOKIPA Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network